Certified by Founder
Lodge
Lassen Therapeutics
start up
United States
- San Diego, California
- 21/12/2023
- Series B
- $85,000,000
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
- Industry Biotechnology Research
- Website https://lassentherapeutics.com/
- LinkedIn https://www.linkedin.com/company/lassen-therapeutics/
Simple AI | $14,000,000 | (Feb 12, 2026)
Hubbl Technologies | $6,000,000 | (Feb 12, 2026)
Trener Robotics (formerly T-ROBOTICS) | $32,000,000 | (Feb 12, 2026)
Complyance | $20,000,000 | (Feb 12, 2026)
Tenna Systems | $13,500,000 | (Feb 12, 2026)
GitGuardian | $50,000,000 | (Feb 12, 2026)
Inertia | $450,000,000 | (Feb 12, 2026)
Birch Hill Holdings | $2,500,000 | (Feb 12, 2026)
Smart Bricks | $5,000,000 | (Feb 12, 2026)
Scala | $8,500,000 | (Feb 12, 2026)
Loyal | $100,000,000 | (Feb 12, 2026)